To determine if the expression of green¯uorescent protein (GFP) during spermatogenesis can compromise the fertility of transgenic animals, we have produced mouse transgenic lines expressing GFP in the testis under the control of the potent immediate early promoter and enhancer region of the human cytomegalovirus (CMV). GFP expression was detected in the germ cells with no apparent effect on the fertility of any of the ®ve transgenic lines studied. We demonstrate that the CMV promoter is transcriptionally active in the testes of mice aged 7 days. However, protein could be visually detected only after day 10. GFP was not found either in mature spermatozoa or in Sertoli cells, but it was evident in round spermatids from seminiferous tubules and in cytoplasmic drops of spermatozoa from the epididymis. We also detected GFP in spermatogonia expressing c-kit, which indicates that GFP expression driven by the CMV promoter takes place during the proliferative phase of spermatogenesis. The expression of GFP during spermatogenesis did not affect the fertility of transgenic mice.
Introduction
The properties of green¯uorescent protein (GFP) as a vital marker of gene expression have been widely described by researchers from many ®elds in a variety of organisms such as bacteria, slime moulds, plants and mammals (Cubbit et al., 1995) . Unlike other markers, GFP requires neither substrate nor pre-treatment for detection, and hence it has generated enormous interest among developmental biologists as a model that allows real-time visualization of cellular events in their natural environment, inside living cells or organisms. However, GFP forms homodimers at moderate to low concentration, and is often cytotoxic (Hanazono et al., 1997) . Moreover, ectopic expression of a foreign protein can interfere with vital functions resulting in a serious impediment in transgenic studies. Mature spermatozoa are highly differentiated cells that need to maintain their structural and biochemical integrity in order to undergo successfully the changes involved in the fertilization process. It might be expected that the expression of transgenic foreign proteins in these highly specialized cells could interfere with speci®c functions related to fertilization. Transgenic mice expressing GFP under a pan-speci®c promoter such as b-actin are fertile (Okabe et al., 1997) . It has been also reported that the expression of a fusion protein under the acrosin promoter in transgenic mice with no apparent effect on sperm function. However, this fusion protein is produced post-meiotically during spermiogenesis and it is kept restricted to a membrane limited organelle (Nakanishi et al., 1999) . To our knowledge, there is no information describing if the expression of GFP at early steps of spermatogenesis can compromise sperm fertilizing ability.
We have produced mouse transgenic lines expressing GFP in the testis under the control of the potent immediate early promoter and enhancer region of the human cytomegalovirus (CMV) in order to analyse if the expression of GFP in germ cells affect the reproductive potential of these cells. The CMV promoter was selected because it is a frequent promoter in many transgenic experiments and it has been reported that it drives lacZ expression in mature spermatozoa in the seminiferous tubules (Baskar et al., 1996) . In this report, we have examined if GFP expression in the testes of transgenic mice has any effect on the fertilizing ability of spermatozoa and what type of germ cells are speci®cally expressing the transgene containing GFP under the control of the CMV promoter.
Materials and methods

Generation and screening of transgenic mice
The generation and identi®cation of transgenic mice (C57BL6xCBA) has been previously described (Gutie Ârrez-Ada Ân & Pintado, 2000) . Brie¯y, a transgene construct linearized by a unique restriction endonuclease digestion was prepared from the plasmid pEGFP-N1 containing the human CMV immediate early promoter and the enhanced GFP gene (pEGFP-N1, Clontech Laboratories Inc., Palo Alto, CA, USA). Transgenic founders were backcrossed to C57BL6xCBA mice to obtain transgenic lines. Polymerase chain reaction (PCR)-positive founder animals were con®rmed by dot blot analysis and both the integrity and the transgene transmission were analysed during two generations.
Preparation of testis cell suspension Cells were collected from transgenic and non-transgenic (control) testes by a modi®ed two-step enzymatic isolation procedure (Bellve Â, 1993) . Brie¯y, testes from 7 to 16-dayold and adult transgenic animals were decapsulated and the tubules dissected apart in 0.1 M phosphate-buffered saline (PBS) pH 7.2 containing 5 lg/mL Dnase I (Boehringer, Mannheim, Germany). After being washed three times by sedimentation, they were incubated in 12 mL of PBS containing 5 lg/mL hyaluronidase IS, 1 mg/mL trypsin and 1 mg/mL collagenase IA (all from Sigma, Madrid, Spain) in a shaking waterbath at 32°C, 50±60 g 1 for 15 min to remove the interstitium. The mixture was pipetted several times until a cell suspension was obtained and washed in PBS to remove trypsin. A second 30 min incubation with the same enzymes except trypsin, was performed to separate the seminiferous epithelial cells. After repeated pipetting, cells were centrifuged at 200 g for 1 min and washed three times in PBS for further experiments.
Analysis of GFP mRNA expression in testes using reverse transcriptase-polymerase chain reaction Poly(A + )RNA was extracted from the testes of transgenic and control mice at different ages using the Ultraspect TM RNA Isolation System (Biotecx Laboratory Inc., Houston, TX, USA) following the manufacturer's instructions. The precipitated mRNA was dissolved in DEPC-treated water, and the RNA was digested with 1 U of RQ DNAse I (Promega, Madrid, Spain) at 37°C for 20 min to ensure that the only source of DNA in PCR was cDNA from cellular RNA. Finally, the RNA was extracted with phenol puri®cation and ethanol precipitation, reconstituted in 50 lL of DEPC-treated water and stored at )70°C until RT±PCR was performed.
The RT±PCR reaction was performed according to the manufacturer's instructions (Epicentre Tech. Corp., Madison, WI, USA). Five micrograms poly (A + )RNA was dissolved in water, heat-denatured (65°C, 2 min) and reverse-transcribed at 37°C for 60 min in a ®nal volume of 25 lL containing 0.5 mM each dNTP, 0.2 lM oligo(dV 2 dT 17 ), MMLV±RT (0.5 lL), RNAsin (0.2 lL), 1Ḿ
MLV±RT buffer and 8 mM DTT. After reverse transcription, PCR was performed adding 5 lL aliquot of each sample to the PCR mix containing the speci®c forward primers GFP-1 (5¢-TGA ACC GCA TCG AGC TGA AGG G-3¢) and GFP-2 (5¢-TCC AGC AGG ACC ATG TGA TCG C-3¢), which speci®cally ampli®ed a 340-bp GFP DNA. Ampli®-cation was undertaken in a total volume of 25 lL [1x of PCR mix containing 1 U Taq polymerase, 2.5 lL 10x buffer (both from Promega), 100 lM each dNTP, 0.1 lM each primer and 1.5 mM MgCl 2 ]. Samples were loaded directly from ice into the heating block at 92°C to minimize the time required to reach denaturation temperatures. The PCR protocol was an initial step of 92°C (2 min), followed by 32 cycles of 92°C (30 sec), 59°C (30 sec) and 72°C (30 sec). The ®nal cycle extension was at 72°C (10 min). PCR products were resolved in 1.5% agarose in TBE buffer, followed by staining with ethidium bromide, and visualized using UV light. Negative control experiments in the absence of template RNA were performed. Generation of the expected fragments was strictly dependent on the presence of RNA in the RT reaction, as demonstrated with b-actin ampli®cation, as a non-competitive internal standard control of the RT±PCR.
Immunocytochemistry A freshly isolated cell suspension (1.5´10 6 cells) was ®xed in 3.7% formaldehyde in PBS, at 37°C for 15 min. Samples were washed brie¯y in PBS containing 0.2% Triton X-100, pre-blocked in PBS containing 2% BSA and 0.2% Tween 20 and incubated for 1 h 30 min on ice with one of three different primary antibodies at a concentration of 1:40; namely a rabbit anti-GFP antiserum IgG Fraction (Clontech, Heidelberg, Germany), goat polyclonal anti-vimentin (Chemicon Int. Inc., Temecula, CA, USA) or goat polyclonal anti c-kit raised against a peptide mapping at the carboxy terminus of mouse c-kit (Oncogene Science Inc., San Diego, CA, USA). Primary antibodies were visualized using¯uorescein-conjugated antirabbit IgG or by rhodamine-conjugated antigoat IgG (both from Chemicon Int. Inc.). Control samples were prepared by omitting the primary antibody. Samples, mounted in glycerol-PBS (9:1), were studied and photographed under a¯uorescence microscope.
Results and discussion
Establishment and transmission of transgenic mice lines Eight lines of transgenic mice carrying the GFP transgene were obtained (Table 1) , six from male founders and two from female founders. The overall rate of transgene incorporation was 20%. The frequency of the G 0 and F 1 transgene line transmission is summarized in Table 1 . As shown, amongst the eight lines tested, the G 0 transmission rates of lines 1, 6, 18 and 23 were above 50%. The low transmission rates observed for the other founder mice were indicative of possible germline mosaicism. The transmission rate of F 1 was close to 50% in all lines analysed, suggesting that gametes carrying these transgenes were as active in fertilization as were non-transgenic gametes.
Expression of GFP in transgenic mouse tissues
It has been reported that the CMV promoter is active in many different tissues of transgenic mice including the testis and germ cells of seminiferous tubules (Baskar et al., 1996) . In this report, we examined testicular GFP expression of transgenic lines and found that all lines showed testis GFP expression and that lines 5, 13 and 23 exhibited a high level of expression in interstitial Leydig's cells and in germ cells of the seminiferous tubules (Table 2) . We also examined the distribution of GFP expression in other organs of these three lines in squash slides from kidney, heart, lung, liver, spleen, striated muscle, endothelium and pancreas. Under these conditions, the three transgenic lines exhibited similar¯u orescence in every examined tissue except in the pancreas, where only samples from line 23 emitted a strong bright green signal, and in spleen where only line 5 had detectable GFP expression (Table 2) . Although lacZ expression driven by the CMV promoter has been reported in heart, striated muscle and smooth muscle of transgenic mice (Baskar et al., 1996) , we did not ®nd GFP expression in these tissues, probably because of the different sensitivity of our detection system.
Expression of GFP in testes cell suspension
Previous studies of the CMV promoter in transgenic mice has revealed that transgene expression extends to the testis. Onset of expression has been detected between 10 and 14 days of age in mice, which coincides with the appearance of zygotene and pachytene primary spermatocytes during early spermatogenesis (Dyck et al., 1999) , and affecting both interstitial Leyding cells and primary spermatocytes (Baskar et al., 1996) . In this work, using direct visualization of testes cell suspensions from transgenic mice, we have found that a bright¯uorescence signal could only be detected in samples from mice aged 10 days and older.
Direct visualization of GFP in testicular samples of adult mice allowed us to detect¯uorescence in primary spermatocytes, round spermatids and in cytoplasmic droplets of epididymal spermatozoa (Fig. 1) . To further characterize which spermatogenetic phase was expressing GFP, we isolated cells from the seminiferous epithelium by sequential enzymatic digestion of 10 day-old mice. Under phase contrast microscopy, several cell types were observed up to and including pre-leptotene primary spermatocytes, as previously described (Bellve Â et al., 1977a, b) . Analysis in vivo for¯uorescence of 10-day-old mice showed that in somatic cells and in germ cell aggregates some individual cells clearly emitted green¯uorescence ( Fig. 2A, B) .
To examine transcriptional activity of the CMV±GFP construct, RT±PCR was undertaken on mRNA obtained from testicular tissue of transgenic mice (lines 5 and 23) killed at different ages (7±15 days of age). The size of the ampli®ed region and the persistence of speci®c ampli®cation following pre-treatment of the template with DNAse I, con®rmed the ampli®ed product as being derived from speci®c RNA. The detection of the positive control b-actin mRNA in the samples assayed for GFP expression demonstrated that reverse transcription was successfully achieved (Fig. 3) . The size of the ampli®ed products from b-actin mRNA was, as expected, different from that derived from genomic DNA (approximately 250 bp), because of the presence of an intron in genomic DNA, and thus con®rming the accuracy of the RT±PCR. We found that in testicular tissues of mice of all the different ages analysed there was transcription of the GFP construct, including the seventh post-natal day which represents the earliest stage of spermatogenesis where two main cell types coexist in the seminiferous epithelium, i.e. Sertoli cells and spermatogonia. As we were able to detect GFP protein expression only after day 10 of age, it is possible that the mRNA synthesized between days 7 and 9 of development in the germ cells is not translated until day 10. Similar results were found in the transgenic lines 23 and 5.
The GFP mRNA expression detected by RT±PCR at day 7 of development suggests that the synthesis of GFP under the CMV promoter occurs at early stages of spermatogenesis, which is in contrast with a previous report (Dyck et al., 1999) in which GFP expression was determined by Northern blot. The lower sensitivity of the Northern blot could be the reason for the difference.
Immunocytochemical analysis of GFP expression in germ cells
To further characterize the cell population expressing GFP protein, immunocytochemical analysis was performed. Freshly prepared cell suspensions from the testes of transgenic mice of different ages (10, 12 and 17-day-old) were subjected to immunocytochemistry using GFP antibodies (as a marker of cells expressing the transgene) and c-kit-antibodies (as a marker of spermatogonia). It is well known that the c-kit receptor is expressed in the male germ cell line (Motro et al., 1991; Sorrentino et al., 1991) , mainly in spermatogonia. Double immuno¯uorescence experiments employing c-kit and GFP antibodies revealed that some of the cells positive for c-kit were also labelled with the GFP antibody ( Fig. 2 C, D) . This con®rms that germ-line expression of GFP starts during spermatogenesis, before spermatogonial differentiation.
Previous studies have shown the presence of vimentin intermediate ®laments in mammalian Sertoli cells (Au Èmuller et al., 1992; Frojdman et al., 1992; Zhu et al., 1997) . This fact prompted us to characterize GFP expression further. Double immunostaining experiments for vimentin (as a marker of Sertoli cells) and GFP was performed in order to examine whether there was expression of the GFP gene in this somatic cell line. The vimentin and GFP immunostaining gave different results in the stages analysed, the vimentinpositive cells were GFP-negative (Fig. 4) , thus indicating that Sertoli cells did not express GFP.
In conclusion, our results strongly suggest that GFP is a safe reporter gene from the reproductive point of view because its expression during the proliferative phase of spermatogenesis and its accumulation in round spermatids and in cytoplasmic droplets of spermatozoa do not affect the fertilizing ability of transgenic mice. 
